GE HEALTHCARE TECH.INC. Cash Flow-to-Debt Ratio
GE HEALTHCARE TECH.INC. cash flow-to-debt ratio. GE HEALTHCARE TECH.INC. (L0T) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of €290.00 Million could theoretically repay 0% of its total liabilities (€26.23 Billion) in one year. Check GE HEALTHCARE TECH.INC. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of GE HEALTHCARE TECH.INC. (2022–2025)
Cash flow-to-debt ratio of GE HEALTHCARE TECH.INC. from 2022 to 2025. Historical debt coverage capacity for GE HEALTHCARE TECH.INC. across 4 annual periods. Check L0T operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
GE HEALTHCARE TECH.INC. Cash Flow-to-Debt Ratio by Year (2022–2025)
GE HEALTHCARE TECH.INC. cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for GE HEALTHCARE TECH.INC.. For the full cash flow conversion analysis, see how efficiently does GE HEALTHCARE TECH.INC. generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | €1.99 Billion | €26.31 Billion | ▼ -5.4% |
| 2024 | 0.08x | €1.95 Billion | €24.44 Billion | ▼ -4.5% |
| 2023 | 0.08x | €2.10 Billion | €25.14 Billion | ▼ -29.0% |
| 2022 | 0.12x | €2.11 Billion | €17.95 Billion | — |